Today, Johns Hopkins University and the Sam Gilliam Foundation announced the launch of the new Sam Gilliam Lecture Series, to be hosted at the Johns Hopkins University Bloomberg Center in Washington, ...
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback